APO-BRIMONIDINE
As listed in the register: APO-BRIMONIDINE
0.2 % · solution
- Prescription only
- Eyes and ears
- Active substance
- Brimonidine Tartrate
- Used in
- Eyes and ears
- Made by
- Apotex Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (BRIMONIDINE). It describes the substance, not this exact product.
Brimonidine is a relatively selective alpha-2 adrenergic agonist.
Topical application of brimonidine topical gel may reduce erythema through direct vasoconstriction.
Brimonidine is extensively metabolized by the liver.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2024-07-31
Safety of the active substance
From the US prescribing label for the same active substance (BRIMONIDINE). It describes the substance, not this exact product.
- Brimonidine topical gel is contraindicated in patients who have experienced a hypersensitivity reaction to any component.
- Reactions have included angioedema, urticarial, and contact dermatitis [ see Warnings and Precautions ( 5.6 ) and Adverse Reactions ( 6.1, 6.2 ) ].
- Known hypersensitivity to any component of brimonidine topical gel ( 4 )
The most common adverse reactions (incidence ≥ 1%) included erythema, flushing, skin burning sensation, and contact dermatitis.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Apotex Inc |
|---|---|
| Active substance | Brimonidine Tartrate |
| Used in | Eyes and ears |
| Strength | 0.2 % |
| Form | solution |
| Classification | S01EA05 · Eyes and ears |
| Route | ophthalmic |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Dormant |
| Marketed | No — authorised but not currently marketed, according to the register |
| DIN | 02260077 |
| DPD drug code | 74531 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.